A new rule in Ohio is designed to bring transparency to drug prices in the pharmacy.
Governor Jerry Brown signed the bill, but will it actually lower drug costs?
Legislators say it will help ease the problem, but the NCPA says it’s just one part of the solution.
The IACP is excited about new legislation that could help compounding pharmacists.
Bills have been introduced in both the Senate and House that are aimed at stopping direct and indirect remuneration fees, assuming they are passed.
The CREATES Act came about because some pharmaceutical manufacturers are misusing the REMS program to prevent generic drug development.
A 60-year debate accompanied the elevation of pharmacy education to the doctoral level. When the provider status bill now moving through Congress is enacted into law, it will put paid to that particular conversation.
More than 300 pharmacists turned out to support H.R. 244, the “MAC Transparency Act," and H.R. 793, the “Ensuring Seniors Access to Local Pharmacies Act of 2015.”
With provider status now a reality in 38 states, HR 592 and S 314 have powerful Congressional support. How long before the payers come on board?
Arizona recently joined around 20 other states by passing a law allowing pharmacists to substitute certain interchangeable biosimilar drugs for brand name drugs.